RxDoctor Payments Data

Cynthia Krause

Women's Health · Muskegon, MINPI 1467427914

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 26.5% of the total. Reporting peaked in 2024 at $987 and has fallen 98.2% since, to $18 in 2025. Among women's health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,923in general payments, 2019–2025

Across 133 payments — averaging $14.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$510
  • Novo Nordisk$305
  • Pfizer$254
  • Lilly USA, LLC$157
  • Astellas Pharma US Inc$147
  • GSK$70
  • plus $479 from 18 others

What the payments were for

  • Food & beverage$1,923100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,923 in reported general payments places this provider in the 90th percentile of 91 women's health providers in Michigan.

See all women's health providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$44,053
OzempicSemaglutide37$39,210
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$24,492
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,033
Albuterol Sulfate HfaAlbuterol Sulfate37$961
Losartan Potassium24$793
Duloxetine Hcl16$712
Estradiol13$551
Metoprolol Succinate27$418
Bupropion XlBupropion Hcl35$387
Dicyclomine Hcl12$375
Potassium Chloride21$339
Levothyroxine Sodium26$299
Atorvastatin Calcium20$242
Glipizide ErGlipizide14$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$47$44,05345 claims
Novo NordiskOzempic$305$39,21037 claims
GSKTrelegy Ellipta$70$24,49237 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 91 women's health providers in Michigan.

Other women's health in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →